About: Comparison of cytokeratin fragment 19 (CYFRA 21-1), tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) as tumour markers in bronchogenic carcinoma

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Comparison of cytokeratin fragment 19 (CYFRA 21-1), tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) as tumour markers in bronchogenic carcinoma Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 March 1997

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в березні 1997 (uk) artículu científicu espublizáu en marzu de 1997 (ast) scientific article published on 01 March 1997 (en) գիտական հոդված հրատարակված 1997 թվականի մարտի 1-ին (hy)
publication date	wds:Q73307769-C74FCB68-C774-4DA6-93DE-1256530E2FE9
publication date	1997-03-01 00:00:00Z (xsd:dateTime)
cites work	wds:Q73307769-0BAB05A2-5F4A-49B2-AC67-95F859362E42 wds:Q73307769-0DD10F53-9129-4F15-9D74-8315A31862BD wds:Q73307769-24467094-ACD0-46EC-A93A-A4F7A099E88D wds:Q73307769-2D5CECAA-82AD-45ED-9784-54A208FC6600 wds:Q73307769-38224FA1-E837-408D-9F78-56F9C5B2815C wds:Q73307769-58BF3F2E-A422-40B5-B08C-85BB0B64A95F wds:Q73307769-5C575191-D1D8-439F-BD9A-80FE0864E168 wds:Q73307769-6880B06A-119C-4058-AAA8-F40CE0EE90C2 wds:Q73307769-7F35D4A9-1127-4993-9723-D763F36AB219 wds:Q73307769-80F84BFD-AB86-449D-B3B9-EC337F51D33A wds:Q73307769-9057A4FD-610B-4835-B33B-D4F979D001C3 wds:Q73307769-90B0EF71-3F4B-4AD7-8D47-2310DAB038B4 wds:Q73307769-96FBAEA9-57F4-43CB-8A5F-4FA94835B8DF wds:Q73307769-A0730D23-9418-448E-AD38-C1D87C5D094F wds:Q73307769-C155A8F4-6629-4AEA-9CAE-8FBC47DB58D5 wds:Q73307769-C4ACCA6D-DB52-4264-B22C-B3F8D662858E wds:Q73307769-D9379997-50A9-4995-AA76-CC64E238F339 wds:Q73307769-ED1E7A77-FB7B-4414-856F-B675404B8144 wds:Q73307769-F60139F4-2788-4A65-9755-0006340587C7
cites work	CYFRA 21-1 as a tumour marker for bronchogenic carcinoma The World Health Organization histological typing of lung tumours. Second edition The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells The meaning and use of the area under a receiver operating characteristic (ROC) curve Cyfra 21-1 as a biologic marker of non-small cell lung cancer. Evaluation of sensitivity, specificity, and prognostic role Intermediate filaments. Looking for a function Evaluation of a new tumour marker in patients with non-small-cell lung cancer: Cyfra 21.1. CYFRA 21-1, a sensitive and specific new tumour marker for squamous cell lung cancer. Report of the first European multicentre evaluation. CYFRA 21-1 Multicentre Study Group CYFRA 21-1. A new marker in lung cancer Evaluation of a radioimmunoassay for neuron specific enolase in small cell lung cancer Clinical value of a multiple biomarker assay in patients with bronchogenic carcinoma Tumor markers in bronchogenic carcinoma. Superiority of tissue polypeptide antigen to carcinoembryonic antigen and carbohydrate antigenic determinant 19-9. Usefulness of tissue polypeptide antigen in staging, monitoring, and prognosis of lung cancer Clinical evaluation of seven tumour markers in lung cancer diagnosis: can any combination improve the results? Diagnostic and prognostic value of the new tumour marker CYFRA 21-1 in patients with squamous cell lung cancer Clinical Applications of Serum Tumor Markers The value of carcinoembryonic antigen in patients with carcinoma of the lung The role of serum tumour markers to aid the selection of lung cancer patients for surgery and the assessment of prognosis Evaluation of cytokeratin 19 serum fragments (CYFRA 21-1) in patients with lung cancer: results of a multicenter trial
author name string	wds:Q73307769-1CB908CC-B0CA-4B3C-96DE-B36763D5CC66 wds:Q73307769-66364A0C-7F81-4185-8D76-21BDCFE88D0F wds:Q73307769-8BAE49BC-C4B9-40C6-A662-7762779E1DC3 wds:Q73307769-8F360657-52B4-4027-8852-A7342825218E wds:Q73307769-B593370D-CEFA-485F-A062-5539DFBE7843 wds:Q73307769-D859D505-611C-4474-B13E-D9BE4120547E wds:Q73307769-E006E940-C83C-4323-B7D1-ECDBE9E7EE1E
author name string	M S Huang M S Tsai J J Hwang H C Lin M S Lin S B Jong I W Chong
rdfs:label	Comparison of cytokeratin fragment 19 (CYFRA 21-1), tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) as tumour markers in bronchogenic carcinoma (en) Comparison of cytokeratin fragment 19 (CYFRA 21-1), tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) as tumour markers in bronchogenic carcinoma (nl)
skos:prefLabel	Comparison of cytokeratin fragment 19 (CYFRA 21-1), tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) as tumour markers in bronchogenic carcinoma (en) Comparison of cytokeratin fragment 19 (CYFRA 21-1), tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) as tumour markers in bronchogenic carcinoma (nl)
name	Comparison of cytokeratin fragment 19 (CYFRA 21-1), tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) as tumour markers in bronchogenic carcinoma (en) Comparison of cytokeratin fragment 19 (CYFRA 21-1), tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) as tumour markers in bronchogenic carcinoma (nl)
title	wds:Q73307769-2B6206E5-D04B-42B4-830B-B45F4589E5A6
title	Comparison of cytokeratin fragment 19 (CYFRA 21-1), tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) as tumour markers in bronchogenic carcinoma (en)
page(s)	wds:Q73307769-91ACD0B9-7D40-4EB4-874C-E2D275EB58D2
page(s)	135-142
instance of	wds:Q73307769-6CED2A25-17DE-4331-A8B5-8095A3ACDFB1
instance of	scholarly article
PubMed ID	wds:Q73307769-AAB5DD2D-0265-4BDD-850B-46EA5D9CD9C7
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9135852
PubMed ID	9135852
published in	wds:Q73307769-21F24D13-96C5-4C1B-9431-F1FBDB4EB893
published in	Respiratory Medicine
issue	wds:Q73307769-26A8A972-5AE3-48D2-AB49-8DB83AE9F544
volume	wds:Q73307769-CE5BDB57-63D0-48DB-80FF-39A45966613D
issue	3
volume	91
DOI	wds:Q73307769-0CF0DAB1-5F63-48A6-BFE1-A892E6C77E88
DOI	http://dx.doi.org/10.1016/S0954-6111(97)90049-4
DOI	10.1016/S0954-6111(97)90049-4
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73307769
is cites work of	Diagnostic value of CEA, CA 15-3, CA 19-9, CYFRA 21-1, NSE and TSA assay in pleural effusions Tumor markers in lung cancer: does the method of obtaining the cut-off point and reference population influence diagnostic yield? Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, and cytokeratin 19 fragments in patients with effusion from nonsmall cell lung cancer Diagnostic value of cytokeratin fragment 19 (CYFRA 21-1) in bronchoalveolar lavage fluid in lung cancer. Lung tumor markers of cytokeratin origin: an overview
is cites work of	wds:Q39979880-99547058-AB68-4ED9-9125-8C9048889B31 wds:Q52237477-4B1EE2BE-FBAA-419C-AD76-0773FC3D670F wds:Q40779071-C9926D6B-B225-44C8-9C9F-4CDBCD0D441C wds:Q73405871-A97918D3-2AB7-4360-8D10-302617FEB651 wds:Q34447427-DF0C9462-E6D8-48C2-A44A-EDA59C8013D9

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software